LYMPHATIC MAPPING AND SENTINEL NODE BIOPSY

Course overview

UAN: 0018-0000-18-201-H01-P UAN: 0018-0000-18-201-H01-T RELEASE: 10/22/2018 EXPIRE: 10/22/2021 CREDITS: 1.75 LEARNING OBJECTIVES: 1. Describe the lymphatic system and the sentinel lymph node concept of metastatic spread of solid tumors. 2. Describe the injection procedures, nuclear medicine imaging (lymphoscintigraphy), intraoperative lymphatic mapping and sentinel lymph node biopsy techniques. 3. Discuss how sentinel lymph node biopsy helps in the staging of cancer. 4. List the radiopharmaceuticals used for lymphatic mapping/sentinel lymph node biopsy and compare/contrast their different properties 5. Describe the nuclear medicine clinical procedure involving lymphatic mapping/sentinel lymph node biopsy 6. Discuss developments in radiopharmaceuticals and instrumentation associated with lymphatic mapping/sentinel lymph node biopsy 7. List three disease states where lymphatic mapping/imaging is valuable for patient care. NOTE: An annual subscription for Purdue¿s nuclear pharmacy recertification program provides access to both the continuing education component of the program and the ¿Radiopharmacy Portal,¿ a reference resource for practitioners. Subscriptions to the continuing educational offerings, which have been accredited through ACPE and BPS, can be purchased for an annual fee of $195 for nuclear pharmacists and $95 for nuclear pharmacy technicians.